Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
PaperCitations, authors & open-access status
Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 43 citations, 2022 year and gold oa status.
43
Citations
2022
Year
gold
OA Status